COVID-19 Vaccination Could Start December 11
Pfizer’s coronavirus vaccine could be approved and roll out across the U.S. at the end of the second week in December, Moncef Slaoui, the chief science adviser for Operation Warp Speed, said.
Pfizer’s coronavirus vaccine could be approved and roll out across the U.S. at the end of the second week in December, Moncef Slaoui, the chief science adviser for Operation Warp Speed, said.
Can you separate fact from fiction when it comes to PROS? Test your knowledge with this quiz.
This summary of NICE’s guideline covers how to make shared decision making part of everyday care in secondary healthcare settings
The size of the human brain has increased over time, a new finding that may help explain a previously reported decline in incident dementia.
PROS is a group of rare congenital disorders characterized by overgrowth ranging from isolated digits to whole limbs and beyond. What conditions are in the…
Patients with advanced EGFR-mutated NSCLC who were given osimertinib plus chemotherapy up front continue to show improved outcomes after initial progression, suggests ongoing trial data.
San Diego Mission Bay Resort San Diego, California For 27 years, the Acute Leukemia Forum (ALF) has provided a unique platform that enables the world’s…
A tabular comparison of recommendations from NICE, ESC, and ACC/AHA/HRS guidelines on rate and rhythm control in atrial fibrillation
Inflammatory bowel disease therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not increase flares.
Two recent studies revealed the compounding effects of negative social determinants of health on worse disease presentation and activity over time.
Hospitalization for influenza raises the risk for future neurologic conditions more than hospitalization for COVID-19, the results of a large study showed.